Pacira BioSciences (PCRX) Debt to Equity (2008 - 2026)
Pacira BioSciences (PCRX) debt to equity from Dec 31, 2008 to Mar 31, 2026. The current Pacira BioSciences (PCRX) debt to equity is 56.23%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Pacira BioSciences (PCRX)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 53.70% | -28.59% |
| 2024 | 75.20% | +23.21% |
| 2023 | 61.03% | -31.39% |
| 2022 | 88.96% | +85.41% |
| 2021 | 47.98% | +98.69% |
| 2020 | 24.15% | N/A |
| 2019 | 0.00% | -100.00% |
| 2018 | 0.11% | -7.56% |
| 2017 | 0.11% | -99.89% |
| 2016 | 103.79% | +1.84% |
| 2015 | 101.91% | -21.82% |
| 2014 | 130.35% | -55.19% |
| 2013 | 290.91% | +660.59% |
| 2012 | 38.25% | -27.83% |
| 2011 | 52.99% | -202.35% |
| 2010 | -51.78% | N/A |
| 2009 | 0.00% | N/A |
| 2008 | 0.00% | N/A |
Comparison Pacira BioSciences (PCRX) debt to equity with competitors
Pacira BioSciences (PCRX) debt to equity is 56.23%.